Citigroup
DAWN

Citigroup’s Day One Biopharmaceuticals DAWN Stock Holding History

Citigroup’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$297K Sell
13,848
-10,246
-43% -$144K ﹤0.01% 3806
2025
Q4 		$225K Buy
24,094
+16,121
+202% +$135K ﹤0.01% 3945
2025
Q3 		$56.2K Sell
7,973
-100,398
-93% -$691K ﹤0.01% 4453
2025
Q2 		$704K Sell
108,371
-56,305
-34% -$387K ﹤0.01% 3405
2025
Q1 		$1.31M Buy
164,676
+8,442
+5% +$90.9K ﹤0.01% 3054
2024
Q4 		$1.98M Buy
156,234
+108,164
+225% +$1.51M ﹤0.01% 2831
2024
Q3 		$670K Buy
48,070
+14,065
+41% +$201K ﹤0.01% 3545
2024
Q2 		$469K Sell
34,005
-137,045
-80% -$2.01M ﹤0.01% 3431
2024
Q1 		$2.83M Buy
171,050
+71,125
+71% +$1.06M ﹤0.01% 2141
2023
Q4 		$1.46M Sell
99,925
-740
-0.7% -$8.97K ﹤0.01% 2514
2023
Q3 		$1.24M Buy
100,665
+4,234
+4% +$55.2K ﹤0.01% 2340
2023
Q2 		$1.15M Sell
96,431
-56,567
-37% -$739K ﹤0.01% 2731
2023
Q1 		$2.05M Buy
152,998
+62,985
+70% +$1.23M ﹤0.01% 2007
2022
Q4 		$1.94M Sell
90,013
-41,733
-32% -$856K ﹤0.01% 2067
2022
Q3 		$2.64M Buy
131,746
+128,981
+4,665% +$2.74M ﹤0.01% 1948
2022
Q2 		$49K Buy
2,765
+562
+26% +$5.8K ﹤0.01% 4547
2022
Q1 		$22K Sell
2,203
-2,479
-53% -$32.8K ﹤0.01% 5095
2021
Q4 		$79K Buy
4,682
+3,403
+266% +$69.9K ﹤0.01% 4836
2021
Q3 		$30K Buy
+1,279
New +$30.7K ﹤0.01% 5025

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Citigroup's DAWN Position: Q1 2026 in Review

Citigroup reduced its Day One Biopharmaceuticals (DAWN) stake by 43% in Q1 2026, selling an estimated $144K and leaving 13,848 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #3806.

Citigroup first reported a position in DAWN in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.83M in Q1 2024. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Citigroup held 13,848 shares of Day One Biopharmaceuticals worth $297K as of Q1 2026.
  • Citigroup sold 10,246 Day One Biopharmaceuticals shares in Q1 2026, an estimated $144K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3806 holding.
  • Citigroup first reported a position in Day One Biopharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Citigroup's Day One Biopharmaceuticals position peaked at $2.83M in Q1 2024.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.